IARTIntegra LifeSciences Holdings Corporation

$747M

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$384M+4.8% YoY

Gross Profit

$240M62.6% margin

Operating Income

$46M12.0% margin

Net Income

$30M7.8% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$78M

Free Cash Flow

$60M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.9B

Stockholders' Equity

$1.4B

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$384M	$366M	+4.8%
Gross Profit	$240M	$229M	+5.0%
Operating Income	$46M	$28M	+66.3%
Net Income	$30M	$11M	+161.4%

Revenue Segments

Codman Specialty Surgical

$249M65%

Orthopedics and Tissue Technologies

$134M35%

Geographic Segments

UNITED STATES

$273M71%

Europe

$51M13%

Asia Pacific

$37M10%

Rest Of World

$22M6%

IART Q2 2019 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena